Table 2 Patient characteristics.
Patients | |
|---|---|
Age (years) | |
Median | 69 |
Range | 48–82 |
Pretreatment PSA | n (%) |
≤ 10 ng/mL | 37 (39) |
> 10 ng/mL | 57 (61) |
Gleason score | n (%) |
6 | 55 (59) |
7 | 30 (32) |
8 | 3 (3) |
9 | 6 (6) |
Stage | n (%) |
T1 | 12 (13) |
T2 | 63 (67) |
T3 | 19 (20) |
Patients | |
|---|---|
Age (years) | |
Median | 69 |
Range | 48–82 |
Pretreatment PSA | n (%) |
≤ 10 ng/mL | 37 (39) |
> 10 ng/mL | 57 (61) |
Gleason score | n (%) |
6 | 55 (59) |
7 | 30 (32) |
8 | 3 (3) |
9 | 6 (6) |
Stage | n (%) |
T1 | 12 (13) |
T2 | 63 (67) |
T3 | 19 (20) |